Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

Cellarity CEO Ted Myles will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:00 a.m. PST.

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Cancer is the second leading cause of death worldwide. Since age is one of the risk factors for the development of cancer, ...

The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...